Diagnostic relevance of overexpressed Nanog gene in early lung cancers

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 587-591

  Nirasawa, Shinya ^a   Kobayashi, Daisuke ^a   Tsuji, Naoki ^a   Kuribayashi, Kageaki ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnosis; Early stages; Lung cancer; mRNA expression; Nanog; TaqMan RT PCR

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR NANOG; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TISSUE LEVEL; TUMOR VOLUME; CANCER STAGING; GENETICS; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 70349312851     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000476     Document Type: Article

References (13)

1. Betticher DC: Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift. Lung Cancer 50: S9-S16, 2005.
2. Mitsui K, Tokuzawa Y, Itoh H, et al: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642, 2003.
3. Chambers I, Colby D, Robertson M, et al: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655, 2003.
4. Yasuda SY, Tsuneyoshi N, Sumi T, et al: NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells 11: 1115-1123, 2006.
5. Liu N, Feng X, Fang Z, Ma F, Lu S, Lu M and Han Z: Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation. J Cell Biochem 104: 2348-2362, 2008.
6. Okita K, Ichisaka T and Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007.
7. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
8. Ye F, Zhou C, Cheng Q, Shen J and Chen H: Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 8: 108-112, 2008.
9. Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S and Watanabe N: Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer 46: 299-304, 2004.
10. Amachika T, Kobayashi D, Moriai R, Tsuji N and Watanabe N: Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers. Lung Cancer 56: 337-340, 2007.
11. Bourguignon LY, Peyrollier K, Xia W and Gilad E: Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 283: 17635-17651, 2008.
12. Ezeh UI, Turek PJ, Reijo RA and Clark AT: Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265, 2005.
13. Ben-Porath I, Thomson MW, Carey VJ, et al: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507, 2008.